PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
2.640
0.00 (0.00%)
Oct 14, 2026, 9:43 AM EDT - Market open
PAVmed Stock Forecast
PAVM's stock price has decreased by -81.99% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, PAVmed stock has a consensus rating of "Buy" and an average price target of $36.5. The average 1-year stock price forecast is 1,282.58% higher than the current stock price, while the lowest is $16 (+506.06%) and the highest is $57 (+2,059.09%).
Price Target: $36.5 (+1,282.58%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 27, 2026.
Analyst Ratings
The average analyst rating for PAVmed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $56 → $57 | Buy | Maintains | $56 → $57 | +2,059.09% | Aug 27, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $16 | Buy | Reiterates | $16 | +506.06% | Aug 15, 2026 |
Financial Forecast
Revenue This Year
165.00K
from 71.00K
Increased by 132.39%
Revenue Next Year
600.00K
from 165.00K
Increased by 263.64%
EPS This Year
-2.33
from -4.69
EPS Next Year
-2.38
from -2.33
EPS and Forward PE are based on non-GAAP adjusted numbers.